Modified BPaL Regimen for Managing Pre-XDR TB and MDR (TI/NR) TB in India

Conditions:   Pre-Extensively Drug-Resistant Pulmonary TB;   Treatment Intolerant Multidrug-Resistant Pulmonary TB;   Non-responsive Multidrug-Resistant Pulmonary TB Interventions:   Drug: Linezolid;   Drug: Bedaquiline;   Drug: Pretomanid Sponsors:   Tuberculosis Research Centre, India;   International Union Against Tuberculosis and Lung Diseases;   Sarvodaya Charitable Trust Hospital, Ghatkopar, Mumbai;   Shatabdi Centenary Hospital, Govandi, Mumbai;   KGMU, Lucknow;   SN Medical College, Agra;   BJ Medical College, Ahme dabad;   Govt. Medical College, Surat;   NITRD, New Delhi;   RBIPMT, Delhi Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials